Artificial Joints

Artificial Joints

Global Artificial Joints Market to Reach US$35.9 Billion by 2030

The global market for Artificial Joints estimated at US$26.5 Billion in the year 2023, is expected to reach US$35.9 Billion by 2030, growing at a CAGR of 4.4% over the analysis period 2023-2030. Ceramics Material, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$17.3 Billion by the end of the analysis period. Growth in the Alloys Material segment is estimated at 4.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$7.2 Billion While China is Forecast to Grow at 4.0% CAGR

The Artificial Joints market in the U.S. is estimated at US$7.2 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$5.6 Billion by the year 2030 trailing a CAGR of 4.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.4% and 3.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Global Artificial Joints Market - Key Trends and Drivers Summarized

Why Are Artificial Joints Becoming a Critical Solution for Mobility Issues?

Artificial joints have become a vital solution for individuals suffering from severe joint pain and mobility issues, particularly those resulting from conditions like osteoarthritis, rheumatoid arthritis, and traumatic injuries. These prosthetic devices are designed to replace damaged or diseased joints, restoring function and alleviating pain, thereby significantly improving the quality of life for patients. Hip and knee replacements are the most common types of artificial joint surgeries, but shoulder, elbow, and ankle replacements are also gaining traction as the technology advances. The increasing prevalence of joint-related ailments, driven by aging populations and rising obesity rates, has led to a growing demand for joint replacement surgeries. This demand is further fueled by the desire of patients to maintain an active lifestyle well into their later years, making artificial joints an indispensable part of modern orthopedic medicine.

How Are Technological Advancements Enhancing the Performance of Artificial Joints?

Technological advancements have played a crucial role in enhancing the design, durability, and functionality of artificial joints, making them more effective and long-lasting. The development of new materials, such as highly cross-linked polyethylene and advanced ceramics, has significantly improved the wear resistance of artificial joints, reducing the risk of complications like implant loosening or dislocation. Additionally, the use of 3D printing technology has enabled the customization of implants to better fit individual patients, leading to improved outcomes and faster recovery times. Advances in surgical techniques, such as minimally invasive surgery and robotic-assisted procedures, have also contributed to the success of joint replacement surgeries by reducing recovery times and minimizing the risk of infection. Moreover, innovations in biocompatible coatings and surface treatments have improved the integration of artificial joints with bone tissue, enhancing their longevity and performance. These technological strides are making artificial joints more reliable and accessible to a broader range of patients, driving the growth of joint replacement procedures worldwide.

What Trends Are Shaping the Adoption of Artificial Joints in Healthcare?

Several key trends are influencing the adoption of artificial joints in healthcare, reflecting broader changes in medical practice and patient preferences. One significant trend is the shift towards value-based healthcare, where the focus is on improving patient outcomes and satisfaction while reducing costs. This has led to an emphasis on advanced joint replacement technologies that offer better long-term results and fewer complications, aligning with the goals of value-based care. The growing popularity of outpatient joint replacement surgeries is another trend, driven by advancements in anesthesia and pain management techniques that allow patients to return home on the same day as their surgery. Additionally, the increasing availability of joint replacement surgeries in emerging markets, where healthcare infrastructure is rapidly improving, is expanding access to these life-changing procedures. The trend towards patient-centered care, where treatments are tailored to the individual needs and preferences of patients, is also driving the adoption of more personalized and less invasive joint replacement solutions.

What Factors Are Driving the Growth of the Artificial Joints Market?

The growth in the artificial joints market is driven by several factors that are reshaping the landscape of orthopedic care. One of the primary drivers is the aging global population, as older adults are more likely to suffer from joint-related conditions that require surgical intervention. The rising incidence of obesity and related joint issues is also contributing to the increased demand for joint replacements. Technological advancements in implant materials, design, and surgical techniques are enhancing the effectiveness and durability of artificial joints, making them more appealing to both patients and healthcare providers. The expansion of healthcare infrastructure in emerging markets is opening up new opportunities for joint replacement surgeries, particularly as more patients in these regions gain access to advanced medical care. Additionally, the shift towards outpatient and minimally invasive procedures is making joint replacement surgeries more convenient and less costly, further driving market growth. As these trends continue to evolve, the artificial joints market is poised for sustained expansion, driven by innovation, demographic shifts, and the growing need for effective mobility solutions.

Select Competitors (Total 46 Featured) -

• Aikang Medical Holdings Co., Ltd.
• Arthrex, Inc.
• B. Braun Melsungen AG
• DePuy Synthes
• DJO Global, Inc.
• Exactech, Inc.
• Globus Medical, Inc.
• JRI Orthopaedics Ltd.
• Medtronic PLC
• NuVasive, Inc.
• SAMO SpA
• Smith & Nephew PLC
• Stryker Corporation
• Zimmer Biomet Holdings, Inc.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.